# SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE
> **ANDA212903** · Abbreviated New Drug Application (Generic) · Sponsor: ANNORA PHARMA · Approved 2024-10-18
## Drug
- **FDA Application Number:** ANDA212903
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE
- **Generic name:** SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE
- **Active ingredients:** MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ANNORA PHARMA
- **Manufacturer:** Camber Pharmaceuticals, Inc.
- **First approval:** 2024-10-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212903)
---
*MORVS · CC0 1.0*